Actinium Pharmaceuticals reported $-16.43M in EBITDA for its fiscal quarter ending in March of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Actinium Pharmaceuticals USD -16.43M 9.13M Mar/2025
Amgen USD 5.14B 775M Dec/2025
Bioline Rx USD -554K 2.93M Sep/2025
Capricor Therapeutics USD -24.58M 17.26M Mar/2025
Pfizer USD 6.08B 351M Sep/2025